Molecular Cancer

Call for Papers: New Thematic Series

For the third consecutive year, Molecular Cancer is excited to announce a new thematic series covering the general research area of Non-coding RNAs and RNA modifiers in cancer progression and cancer cells resistance to therapies. Of particular focus are original research papers reporting data from clinical trials or animal models. In addition to original research articles, we aim to publish letters to the Editor and comprehensive reviews.

All submitted manuscripts will undergo rigorous initial evaluation within 7 days, and then, when appropriate, will be sent out for external peer review to assess the suitability for publication. Submit here.

Submission deadline: December 15^th, 2019

Expected publication date: February 2020

Thematic Series Published in 2019: Microvesicles and Tumor Microenvironment in Cancer Development and Resistance to Therapies

This series of review articles aims to highlight significant findings and advances in our understanding of the role of the TME in cancer biology. The tumor microenvironment (TME) has an effect on tumor development, growth, and resistance to therapy. Continuous interactions and exchanges between tumor cells and the TME are involved in angiogenesis, tumor genetic diversity, immune escape, and metastasis.

Featured Article: Role of the NLRP3 inflammasome in cancer

In this review, Sahebkar et al. summarize the current knowledge on the contribution of the NLRP3 inflammasome on potential cancer promotion and therapy.

Thematic Series Published in 2018

Series of Review Articles: Oncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities

mRNA modification orchestrates cancer stem cell fate decisions

Authors: Weicheng Liang, Zexiao Lin, Cong Du, Dongbo Qiu and Qi Zhang

Content type: Review

26 February 2020
Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance

Authors: Ramesh Pothuraju, Satyanarayana Rachagani, Shiv Ram Krishn, Sanjib Chaudhary, Rama Krishna Nimmakayala, Jawed A. Siddiqui, Koelina Ganguly, Imayavaramban Lakshmanan, Jesse L. Cox, Kavita Mallya, Sukhwinder Kaur and Surinder K. Batra

Content type: Research

25 February 2020
Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme

Authors: Mathilde Cheray, Amandine Etcheverry, Camille Jacques, Romain Pacaud, Gwenola Bougras-Cartron, Marc Aubry, Florent Denoual, Pierre Peterlongo, Arulraj Nadaradjane, Joséphine Briand, Farida Akcha, Dominique Heymann, François M. Vallette, Jean Mosser, Benjamin Ory and Pierre-François Cartron

Content type: Research

25 February 2020
lncRNA-PLACT1 sustains activation of NF-κB pathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer

Authors: Xiaofan Ren, Changhao Chen, Yuming Luo, Mingyang Liu, Yuting Li, Shangyou Zheng, Huilin Ye, Zhiqiang Fu, Min Li, Zhihua Li and Rufu Chen

Content type: Research

21 February 2020
Functions and clinical significance of circular RNAs in glioma

Authors: Jikui Sun, Banban Li, Chang Shu, Quanfeng Ma and Jinhuan Wang

Content type: Review

15 February 2020

Most recent articles RSS

View all articles

Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer

Authors: Ruochuan Sun, Jifeng Wu, Yuanyuan Chen, Mingdian Lu, Shangxin Zhang, Daru Lu and Yongxiang Li

Content type: Research

28 September 2014
The complexity of NF-κB signaling in inflammation and cancer

Authors: Bastian Hoesel and Johannes A Schmid

Content type: Review

2 August 2013
Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer

Authors: Donatella Del Bufalo, Marianna Desideri, Teresa De Luca, Marta Di Martile, Chiara Gabellini, Valentina Monica, Simone Busso, Adriana Eramo, Ruggero De Maria, Michele Milella and Daniela Trisciuoglio

Content type: Research

9 October 2014
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

Authors: María M Caffarel, Clara Andradas, Emilia Mira, Eduardo Pérez-Gómez, Camilla Cerutti, Gema Moreno-Bueno, Juana M Flores, Isabel García-Real, José Palacios, Santos Mañes, Manuel Guzmán and Cristina Sánchez

Content type: Research

22 July 2010
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Authors: Mildred Felder, Arvinder Kapur, Jesus Gonzalez-Bosquet, Sachi Horibata, Joseph Heintz, Ralph Albrecht, Lucas Fass, Justanjyot Kaur, Kevin Hu, Hadi Shojaei, Rebecca J Whelan and Manish S Patankar

Content type: Review

29 May 2014

Most accessed articles RSS

View all articles

Editor-in-Chief

Christophe Nicot, Kansas University Medical Center, USA

Aims and scope

Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.

Molecular Cancer

Call for Papers: New Thematic Series

Thematic Series Published in 2019: Microvesicles and Tumor Microenvironment in Cancer Development and Resistance to Therapies

Featured Article: Role of the NLRP3 inflammasome in cancer

Thematic Series Published in 2018

Articles

mRNA modification orchestrates cancer stem cell fate decisions

Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance

Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme

lncRNA-PLACT1 sustains activation of NF-κB pathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer

Functions and clinical significance of circular RNAs in glioma

Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer

The complexity of NF-κB signaling in inflammation and cancer

Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Editor-in-Chief

Aims and scope

Follow

Annual Journal Metrics

Molecular Cancer

Contact us